We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

127 hedge funds and large institutions have $872M invested in Avidity Biosciences in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,513% more call options, than puts

Call options by funds: $2.31M | Put options by funds: $24K

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

39% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 31

15% more capital invested

Capital invested by funds: $757M → $872M (+$115M)

10% more funds holding

Funds holding: 115 → 127 (+12)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.33% less ownership

Funds ownership: 104.79% → 102.46% (-2.3%)

Holders
127
Holders Change
+12
Holders Change %
+10.43%
% of All Funds
2.19%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
43
Reduced
31
Closed
13
Calls
$2.31M
Puts
$24K
Net Calls
+$2.28M
Net Calls Change
-$1.18M

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$29.2M
2
APM
Avidity Partners Management
Texas
+$9.94M
3
Goldman Sachs
Goldman Sachs
New York
+$8.33M
4
RI
RTW Investments
New York
+$7.19M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.28M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$51.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.6M
3
Alkeon Capital Management
Alkeon Capital Management
New York
-$12.4M
4
GPP
Great Point Partners
Connecticut
-$7.26M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
76
Victory Capital Management
Texas
$324K +$6.92K +362 +2%
Tudor Investment Corp
77
Tudor Investment Corp
Connecticut
$322K -$80.8K -4,226 -18%
NL
78
NWAM LLC
Washington
$322K – – –
VOYA Investment Management
79
VOYA Investment Management
Georgia
$321K +$20.5K +1,072 +6%
PVI
80
Pura Vida Investments
New York
$302K +$354K +18,506 New
VF
81
Virtu Financial
New York
$298K +$35.9K +1,875 +11%
HS
82
HighVista Strategies
Massachusetts
$283K -$144K -7,530 -30%
SG Americas Securities
83
SG Americas Securities
New York
$279K -$269K -14,069 -45%
Legal & General Group
84
Legal & General Group
United Kingdom
$274K -$51.5K -2,694 -14%
QT
85
Quantamental Technologies
New York
$214K +$251K +13,130 New
Teacher Retirement System of Texas
86
Teacher Retirement System of Texas
Texas
$199K +$233K +12,176 New
Los Angeles Capital Management
87
Los Angeles Capital Management
California
$196K -$108K -5,670 -32%
Ensign Peak Advisors
88
Ensign Peak Advisors
Utah
$187K +$12.6K +660 +6%
EAM
89
Erste Asset Management
Austria
$182K – – –
CSS
90
Cubist Systematic Strategies
Connecticut
$182K +$213K +11,135 New
DY
91
Dowling & Yahnke
California
$175K -$11.3K -590 -5%
Principal Financial Group
92
Principal Financial Group
Iowa
$175K +$205K +10,697 New
YIH
93
Y-Intercept (HK)
Hong Kong
$172K +$202K +10,539 New
TRCT
94
Tower Research Capital (TRC)
New York
$168K -$13.9K -727 -7%
SEI Investments
95
SEI Investments
Pennsylvania
$167K +$195K +10,199 New
XT
96
XTX Topco
Cayman Islands
$166K +$194K +10,138 New
ASRS
97
Arizona State Retirement System
Arizona
$166K +$194K +10,142 New
ProShare Advisors
98
ProShare Advisors
Maryland
$164K +$192K +10,032 New
JG
99
Jefferies Group
New York
$163K +$191K +10,000 New
TYCC
100
Texas Yale Capital Corp
Florida
$163K – – –
2 3
4
5 6

RNAM Hedge Fund Activity: Q3 2022 in Review

127 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q3 2022, worth a combined $872M — up 15% from $757M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new RNAM positions and 13 closed out — a net gain of 12 holders — while 43 added to existing stakes and 31 trimmed.

The largest buyer was Cowen and Company, adding an estimated $29.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $51.9M.

  • 127 institutional investors held Avidity Biosciences (RNAM) as of Q3 2022, up from 115 in Q2 2022.
  • Funds reported $872M of Avidity Biosciences stock for Q3 2022, up 15% quarter-over-quarter.
  • 25 funds opened new Avidity Biosciences positions in Q3 2022 and 13 closed out, a net change of +12 holders.
  • The largest Avidity Biosciences buyer in Q3 2022 was Cowen and Company, an estimated $29.2M added.
  • The largest Avidity Biosciences seller in Q3 2022 was T. Rowe Price Associates, an estimated $51.9M sold.

Based on aggregated 13F filings for Q3 2022.